secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNBX Pharmaceuticals Inc. (CNBX)
CIK:        0001343009
Form:       8-K
Filed at:   2021-07-19T23:59:59+00:00
Accession:  0001683168-21-003010
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cannabics Pharmaceuticals appoints Dr. Gil Feiler as Independent Board Member
-----------------------------------------------------------------------------

- Dr. Gil Feiler appointed as Independent Board Member effective July 15, 2021.
- Feiler brings 25+ years executive experience; director of Bank of Georgia, former board member of First International Bank of Israel.
- Feiler also heads company's Advisory Board; holds BA, MA, and PhD from Tel Aviv University.
- Appointment made by Board resolution; no other changes to board or management disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1343009/000168316821003010/0001683168-21-003010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1343009/000168316821003010/cannabics_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-21-003010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer